Extent of Liver Injury as a Predictor of Response to Interferon Combination Therapy

Background: To determine the value of extent of liver injury as a baseline predictor of response to conventional interferon plus ribavirin for chronic hepatitis C Genotype 3 . Methods: In this descriptive study treatment naive hepatitis C patients (n=489) underwent serum Alanine Aminotransferase (AL...

Full description

Bibliographic Details
Main Author: Anum Aqsa
Format: Article
Language:English
Published: Rawalpindi Medical University 2016-06-01
Series:Journal of Rawalpindi Medical College
Subjects:
Online Access:https://www.journalrmc.com/index.php/JRMC/article/view/203
_version_ 1828404950923739136
author Anum Aqsa
author_facet Anum Aqsa
author_sort Anum Aqsa
collection DOAJ
description Background: To determine the value of extent of liver injury as a baseline predictor of response to conventional interferon plus ribavirin for chronic hepatitis C Genotype 3 . Methods: In this descriptive study treatment naive hepatitis C patients (n=489) underwent serum Alanine Aminotransferase (ALT) measurement and a liver biopsy to assess for hepatic steatosis and Histology Activity Index (HAI). Six months conventional interferon plus ribavirin therapy was given to all and the significance of above mentioned parameters as predictors of response in terms of Sustained Virological Response (SVR) and End of Treatment Response (ETR) was analyzed. Chi-square test and regression analysis were used to calculate the results with a significant P value < 0.05. Results: Male individuals constituted 31.1% (n=152) of the population while 68.9% (n=337) were females. Mean Alanine Aminotransferase level was 73.74 ± 65.27 IU/l.SVR was achieved by 61% (n=298) individuals while ETR by 83.4% (n=408). Mild hepatic inflammation and fibrosis i-e-, low HAI (≤8) turned out to be a significant predictor of both a good ETR (p=0.00) and SVR (p=0.00). Minimal to mild degree of steatosis (≤33%) was a predictor of better SVR (0.00). Baseline ALT level was not significantly associated with response rate (p=0.76). Conclusion: Lower extent of hepatic steatosis (≤33%) and low HAI (≤8) is a significant predictor of better response to conventional interferon combination therapy for HCV Genotype 3. Hepatic steatosis >66% and HAI > 12 predicts failure to respond.
first_indexed 2024-12-10T10:45:35Z
format Article
id doaj.art-ae1ef577392c433eb6b0554894140bd5
institution Directory Open Access Journal
issn 1683-3562
1683-3570
language English
last_indexed 2024-12-10T10:45:35Z
publishDate 2016-06-01
publisher Rawalpindi Medical University
record_format Article
series Journal of Rawalpindi Medical College
spelling doaj.art-ae1ef577392c433eb6b0554894140bd52022-12-22T01:52:11ZengRawalpindi Medical UniversityJournal of Rawalpindi Medical College1683-35621683-35702016-06-01202Extent of Liver Injury as a Predictor of Response to Interferon Combination TherapyAnum Aqsa0Department of Medicine, KRL Hospital, IslamabadBackground: To determine the value of extent of liver injury as a baseline predictor of response to conventional interferon plus ribavirin for chronic hepatitis C Genotype 3 . Methods: In this descriptive study treatment naive hepatitis C patients (n=489) underwent serum Alanine Aminotransferase (ALT) measurement and a liver biopsy to assess for hepatic steatosis and Histology Activity Index (HAI). Six months conventional interferon plus ribavirin therapy was given to all and the significance of above mentioned parameters as predictors of response in terms of Sustained Virological Response (SVR) and End of Treatment Response (ETR) was analyzed. Chi-square test and regression analysis were used to calculate the results with a significant P value < 0.05. Results: Male individuals constituted 31.1% (n=152) of the population while 68.9% (n=337) were females. Mean Alanine Aminotransferase level was 73.74 ± 65.27 IU/l.SVR was achieved by 61% (n=298) individuals while ETR by 83.4% (n=408). Mild hepatic inflammation and fibrosis i-e-, low HAI (≤8) turned out to be a significant predictor of both a good ETR (p=0.00) and SVR (p=0.00). Minimal to mild degree of steatosis (≤33%) was a predictor of better SVR (0.00). Baseline ALT level was not significantly associated with response rate (p=0.76). Conclusion: Lower extent of hepatic steatosis (≤33%) and low HAI (≤8) is a significant predictor of better response to conventional interferon combination therapy for HCV Genotype 3. Hepatic steatosis >66% and HAI > 12 predicts failure to respond.https://www.journalrmc.com/index.php/JRMC/article/view/203Conventional interferonRibavirinHistological Activity IndexSteatosisEnd of Treatment ResponseSustained Virological Response
spellingShingle Anum Aqsa
Extent of Liver Injury as a Predictor of Response to Interferon Combination Therapy
Journal of Rawalpindi Medical College
Conventional interferon
Ribavirin
Histological Activity Index
Steatosis
End of Treatment Response
Sustained Virological Response
title Extent of Liver Injury as a Predictor of Response to Interferon Combination Therapy
title_full Extent of Liver Injury as a Predictor of Response to Interferon Combination Therapy
title_fullStr Extent of Liver Injury as a Predictor of Response to Interferon Combination Therapy
title_full_unstemmed Extent of Liver Injury as a Predictor of Response to Interferon Combination Therapy
title_short Extent of Liver Injury as a Predictor of Response to Interferon Combination Therapy
title_sort extent of liver injury as a predictor of response to interferon combination therapy
topic Conventional interferon
Ribavirin
Histological Activity Index
Steatosis
End of Treatment Response
Sustained Virological Response
url https://www.journalrmc.com/index.php/JRMC/article/view/203
work_keys_str_mv AT anumaqsa extentofliverinjuryasapredictorofresponsetointerferoncombinationtherapy